InsiderClue
← All stocks

Kailera Therapeutics, Inc.

KLRA Net buying
CIK 0002096997 #1947 in the set updated 17 Sep 2026
Bought (12 mo)
$326.75M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$326.75M
+$326.75M against sales at will

By person

7 insiders · 6 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BAIN CAPITAL INVESTORS LLC entity
10% owner
$134.38M (1)
—
+$134.38M
26,255,581
20.25%
$420.09M
—
Kaplan Andrew T.
Director
$134.38M (1)
—
+$134.38M
26,255,581
20.25%
$420.09M
—
Bain Capital Life Sciences Investors, LLC entity
10% owner
$25.00M (1)
—
+$25.00M
22,583,268
17.42%
$361.33M
—
Koppel Adam
Director
$25.00M (1)
—
+$25.00M
22,583,268
17.42%
$361.33M
—
RTW INVESTMENTS, LP entity
10% owner
$8.00M (1)
—
+$8.00M
10,776,820
8.31%
$172.43M
—
Jiangsu Hengrui Pharmaceuticals Co., Ltd. entity
10% owner
—
—
—
2,034,133
1.57%
$32.55M
—
Renaud Ronald C JR
CEO & President
—
—
—
38,094
0.0294%
$609.50K
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 20
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 99,582,588
History held since 20 Apr 2026